Overview
NRG Therapeutics is a biotechnology company developing first-in-class, orally bioavailable mitochondrial inhibitors designed to trigger mitochondrial DNA release and activate the cGAS/STING pathway for treating neurodegenerative diseases. The company's therapeutic approach targets pathogenic protein-related conditions, including ALS, through novel mechanisms rooted in neuroscience and mitochondrial biology research.
More in Neurotechnology
Latest industry news
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Tether Evo Takes On One of BCI's Hardest Engineering Problems
2026-09-19 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →